TY - JOUR T1 - Linking gene expression patterns and brain morphometry to trauma and symptom severity in patients with functional seizures JF - medRxiv DO - 10.1101/2021.12.01.21266852 SP - 2021.12.01.21266852 AU - Johannes Jungilligens AU - Stoyan Popkirov AU - David L. Perez AU - Ibai Diez Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/12/02/2021.12.01.21266852.abstract N2 - Objective Adverse life experiences (ALEs) increase the susceptibility to functional (somatoform/dissociative) symptoms, likely through neurodevelopmental effects. This analysis aimed to illuminate potential genetic influences in neuroanatomical variation related to functional symptoms and ALEs in patients with functional seizures.Methods Questionnaires, structural brain MRIs and Allen Human Brain Atlas gene expression information were used to probe the intersection of functional symptom severity (Somatoform Dissociation Questionnaire, SDQ-20), ALE burden, and gray matter volumes in 20 patients with functional seizures.Results Functional symptom severity positively correlated with the extent of sexual trauma, emotional neglect, and threat to life experiences. In voxel-based morphometry analyses, increased SDQ-20 scores related to decreased bilateral insula, left orbitofrontal, right amygdala, and perigenual and posterior cingulate gray matter volumes. Left insula findings held adjusted for psychiatric comorbidities. Increased sexual trauma burden correlated with decreased right posterior insula and putamen volumes; increased emotional neglect related to decreased bilateral insula and right amygdala volumes. The sexual trauma–right insula/putamen and emotional neglect– right amygdala relationships held adjusting for individual differences in psychiatric comorbidities. When probing the intersection of symptom severity and sexual trauma volumetric findings, genes overrepresented in adrenergic, serotonergic, oxytocin, opioid, and GABA receptor signaling pathways were spatially correlated. This set of genes was over-expressed in cortical and amygdala development.Conclusion ALEs and functional symptom severity were associated with gray matter alterations in cingulo-insular and amygdala areas. Transcriptomic analysis of this anatomical variation revealed a potential involvement of several receptor signaling pathways.Competing Interest StatementSP receives royalties from Springer for a book on functional neurological disorders; has received speaking fees from Novartis and Esai. D.L.P. has received honoraria for continuing medical education lectures on functional neurological disorder, and is on the editorial board of Epilepsy & Behavior. The remaining authors have nothing to disclose.Funding StatementThis work was in part funded by a Ruhr University Bochum Research School Gateway Fellowship held by JJ. DLP was funded by NIMH K23MH111983. The funding bodies did not have any role in the design of the study, collection and analysis of data, and decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the Medical Faculty, Ruhr University Bochum gave ethical approval for this work (Reg.-Nr. 17-6019).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized data and analyses scripts will be shared with qualified researchers contingent on approval by the local ethics committee. ER -